factz Jul 26, 2020 Serum Institute of India seeks DCGI permission for phase 2/3 NEW DELHI: Serum Institute of India (SII), which has partnered with AstraZeneca for manufacturing the Oxford candidate for Covid-19 , has sought permission from the Drugs Controller General of India (...
